5 regulatory pivots redefining aseptic manufacturing in 2026

ha aggiunto una foto Health

2026-02-09 05:20:19

As 2026 begins, the National Medical Products Administration has implemented a series of stringent quality consistency evaluations specifically targeting parenteral formulations. These new mandates require all local production facilities to align with high-level international sterile processing standards, fundamentally shifting the focus from volume to high-quality therapeutic equivalence. This...

0 Commenti 0 condivisioni 11 Views 0 Anteprima